Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CERSthis companyCerus Corporation	$2.09	-25.12×	6.11×	1.9×	-85.17×	12.6%	54.5%	-4.2%	-7.6%	-24.3%	-5.2%	2.2%	1.51×	-13.96×	-1.04×	1.73×	0.0%	5	-3.66	2	C
ADMAADMA Biologics, Inc.	$12.89	29.42×	9.11×	8.52×	21.93×	-1122.9%	57.4%	37.5%	28.8%	30.8%	27.6%	0.6%	0.17×	-0.04×	26.93×	6.71×	0.0%	6	7.85	3	B+
HAEHaemonetics Corporation	$121.19	26.36×	3.2×	1.91×	13.14×	-10.2%	55.7%	18.1%	7.3%	12.2%	8.7%	10.2%	1.54×	3.65×	8.41×	2.95×	0.0%	8	3.38	3	B
Peer median	—	27.89×	6.15×	5.22×	17.54×	-566.6%	56.6%	27.8%	18.0%	21.5%	18.1%	5.4%	0.85×	1.8×	17.67×	4.83×	0.0%	7	5.62	3	—